Predictive oncology reports third quarter 2020 financial results, provides business update

New york, nov. 16, 2020 (globe newswire) -- predictive oncology (nasdaq: poai), a knowledge-driven company focused on applying artificial intelligence (“ai”) to personalized medicine and drug discovery, today reported financial results for the quarter ended september 30, 2020 and provided a business update.
POAI Ratings Summary
POAI Quant Ranking